PI: Dorte Damgaard MD PhD, department of neurology Aarhus University Hospital, professor Jens Erik Nielsen-Kudsk department of Clinical Medicine and Cardiology, Aarhus University Hospital.
Purpose: This study is a multicentre randomized clinical trial comparing LAAO with anticoagulant prevention (NOAC) in patients with ischemic stroke or TIA and atrial fibrillation. The study is the first to direct compare effects and safety of LAAO vs NOAC in stroke patients with AF (high risk patients).
Study period: 01 Jun 2018 - ongoing.
Funding: Novo Nordisk Foundation.